These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31612140)

  • 41. Down-regulation of RIP1 by 2-deoxy-D-glucose sensitizes breast cancer cells to TRAIL-induced apoptosis.
    Huang YY; Liu H; Li Y; Pu LJ; Jiang CC; Xu JC; Jiang ZW
    Eur J Pharmacol; 2013 Apr; 705(1-3):26-34. PubMed ID: 23499682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
    Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
    J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sonodynamic Therapy Combined to 2-Deoxyglucose Potentiate Cell Metastasis Inhibition of Breast Cancer.
    Xie L; Feng X; Huang M; Zhang K; Liu Q
    Ultrasound Med Biol; 2019 Nov; 45(11):2984-2992. PubMed ID: 31405605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer.
    Sun L; Yin Y; Clark LH; Sun W; Sullivan SA; Tran AQ; Han J; Zhang L; Guo H; Madugu E; Pan T; Jackson AL; Kilgore J; Jones HM; Gilliam TP; Zhou C; Bae-Jump VL
    Oncotarget; 2017 Sep; 8(38):63551-63561. PubMed ID: 28969010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.
    Pajak B; Siwiak E; Sołtyka M; Priebe A; Zieliński R; Fokt I; Ziemniak M; Jaśkiewicz A; Borowski R; Domoradzki T; Priebe W
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
    Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
    BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps.
    Marín-Hernández Á; Rodríguez-Zavala JS; Del Mazo-Monsalvo I; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
    Front Physiol; 2016; 7():412. PubMed ID: 27721794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
    Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
    Hong SY; Hagen T
    Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease.
    Riwanto M; Kapoor S; Rodriguez D; Edenhofer I; Segerer S; Wüthrich RP
    PLoS One; 2016; 11(1):e0146654. PubMed ID: 26752072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation.
    Pradelli LA; Bénéteau M; Chauvin C; Jacquin MA; Marchetti S; Muñoz-Pinedo C; Auberger P; Pende M; Ricci JE
    Oncogene; 2010 Mar; 29(11):1641-52. PubMed ID: 19966861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
    Khaitan D; Chandna S; Dwarakanath SB
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism.
    Wang Z; Zhang L; Zhang D; Sun R; Wang Q; Liu X
    Mol Med Rep; 2015 Mar; 11(3):1917-24. PubMed ID: 25394852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
    Goetze K; Fabian CG; Siebers A; Binz L; Faber D; Indraccolo S; Nardo G; Sattler UG; Mueller-Klieser W
    Cell Oncol (Dordr); 2015 Oct; 38(5):377-85. PubMed ID: 26288178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of NADPH Oxidase-4 Potentiates 2-Deoxy-D-Glucose-Induced Suppression of Glycolysis, Migration, and Invasion in Glioblastoma Cells: Role of the Akt/HIF1α/HK-2 Signaling Axis.
    Gupta P; Jagavelu K; Mishra DP
    Antioxid Redox Signal; 2015 Sep; 23(8):665-81. PubMed ID: 25891245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Possible mechanism of the selective action of the inhibitors of glycolysis in the endothelial cells and the human carcinoma cells in the culture].
    Giliano NY; Bondarev GN; Konevega LV; Noskin LA; Zhurishkina EV; Alchinova IB
    Patol Fiziol Eksp Ter; 2014; (4):78-85. PubMed ID: 25980231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies.
    Reutter M; Emons G; Gründker C
    Int J Gynecol Cancer; 2013 Jan; 23(1):34-40. PubMed ID: 23154267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death.
    Elankumaran S; Rockemann D; Samal SK
    J Virol; 2006 Aug; 80(15):7522-34. PubMed ID: 16840332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.